Nasdaq Biotechnology Ishares ETF (IBB)
$102.35
0.00 (0.00%)
IBB Stock Quote Delayed 15 Minutes
Previous Close
$102.35
Market Cap
8.90B
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
Day's Range
102.35 - 102.35
52-Week Range
89.01 - 116.25
Dividend & Yield
0.31 (0.31%)
IBB Stock Predictions, Articles, and Nasdaq Biotechnology Ishares ETF News
4 Top Stock Trades for Friday: MU, Biotech, Bitcoin
Bitcoin, Biotech, Micron and Starbucks were our top stock trades to watch. Here's how the charts are setting up going into Friday.
7 Biotech ETFs That Should Remain Healthy
The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.
Why Bristol-Myers Squibb Stock Is Stumbling Ahead of Earnings
Investors turned sour on BMY stock after the Celgene buyout. Will a solid Q2 earnings report change the sentiment for the better?
Nasdaq Today: iQiyi Surges on Award; Intel, Cisco Struggle
Memory stocks like Micron and semiconductor stocks like AMD were on the move in the Nasdaq today. Intel and Cisco weren't so lucky though.
5 Top Stock Trades for Thursday: DPZ, NFLX, IBM
Netflix, IBM, Abbott Labs, Domino's Pizza and the IBB ETF were our top stock trades to watch for Thursday, the last trading day this week.
Is AstraZeneca Stock Worth Buying Before Earnings?
AZN stock is great to own, but you should choose your entry points carefully, as AstraZeneca has some short-term risks ahead.
Trade of the Day: The Biotechnology Stocks ETF Is Running Out of Steam
The charts for the IBB ETF in multiple time frames suggest the recent rally in biotech stocks is overdone for the time being.
IBB is up Over 5%, But the Market May Retest its Lows
This morning I am recommending a bearish trade on the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).
IBB’s $100 Support Level Goes Back to 2017
This morning I am recommending a bullish trade on the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB). I like the biotech sector, and it has generally been holding up well during the recent volatility.
Gilead Sciences Stock Is Back to Base — Go Long
Gilead stock is cheap selling at 11 price-earnings ratio. And it's coming into a long-term support zone. Catch the falling butter knife.
Go Long Pfizer Stock — It’s an Easy Pill to Swallow
PFE is a proven survivor stock and it now sits on a potential long term technical breakout. Go long its potential with confidence.
Trade of the Day: Amgen, Inc. Clears a Breakout Hurdle
Large-cap biotech stocks as a group rallied along with the broader stock market on Wednesday. While so doing, some big names like AMGN stock broke past key near-term technical resistance.
Biotech ETFs Are the Best Way to Play the Recovering Sector
The biotech sector peaked in 2015. While it bounced back from lows, biotech ETFs give investors exposure to the sector as it recovers.
Investors Need to Adopt a Different Mindset for Big Pharma and Biotech Stocks
Both biotech stocks and big pharma stocks involve a different mindset. Treat biotech stocks like options and big pharma stocks like ETFs.
5 Top Stock Trades for Monday Morning
The markets had a big week and bulls are looking to press their luck and fatten their wallets. Here are our top stock trades for Monday.
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
